ALPAW
Get informed when a big investor buys or sells
+ Follow| Market cap | $193.74 Million |
|---|---|
| Enterprise Value | $193.82 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.83 |
| Beta | 0 |
| Outstanding Shares | 1,899,910 |
| P/E Ratio | -2.73 |
|---|---|
| PEG | 55.35 |
| Price to Sales | - |
| Price to Book Ratio | -0.07 |
| Enterprise Value to Revenue | 108.03 |
| Enterprise Value to EBIT | -36.35 |
| Enterprise Value to Net Income | -29 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | -0.06 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tib...